Voriconazole Treatment of Invasive Aspergillosis: Real-World versus Health-Economic Model Results

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.28, Iss.8, 2008-01, pp. : 509-521

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Voriconazole versus Caspofungin for the Treatment of Invasive Aspergillosis in Spain

By Domínguez-Gil Alfonso

Clinical Drug Investigation, Vol. 27, Iss. 3, 2007-01 ,pp. : 197-205

Adis International

Access to resources Recommend Favorite

Voriconazole: In the Treatment of Invasive Aspergillosis

By Muijsers R.B.R. Goa K.L. Scott L.J.

Drugs, Vol. 62, Iss. 18, 2002-01 ,pp. : 2655-2664

Adis International

Access to resources Recommend Favorite

Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting

By Guidotti Mario

Clinical Drug Investigation, Vol. 29, Iss. 11, 2009-11 ,pp. : 693-702

Adis International

Access to resources Recommend Favorite

Voriconazole best value for invasive aspergillosis in Spain

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

First-line voriconazole best option for invasive aspergillosis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 538, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite